Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

Cited by (1,002)

Items 401–500 of 1,002

1. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling
   Xiaolai Yang, Jian Zou, Hongyi Cai, Xiaoling Huang, Xiongfei Yang, Dexi Guo, Yongxiao Cao · 2017 · Biomedicine & Pharmacotherapy
2. Fusobacterium nucleatum Promotes the Progression of Colorectal Cancer Through Cdk5-Activated Wnt/β-Catenin Signaling
   Xiang Li, Jiepeng Huang, Tingting Yu, Xiaoting Fang, Liqin Lou, Shijun Xin, Ling Ji, Feizhao Jiang, Yongliang Lou · 2021 · Frontiers in Microbiology
3. Multi‐Targeted Peptide‐Modified Gold Nanoclusters for Treating Solid Tumors in the Liver
   Feng Xiao, Yao Chen, Jie Qi, Qiaofeng Yao, Jianping Xie, Xingyu Jiang · 2023 · Advanced Materials
4. Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance
   Leila Dadgar-Zankbar, Zahra Elahi, Aref Shariati, Azad Khaledi, Shabnam Razavi, Amin Khoshbayan · 2024 · Cell Communication and Signaling
5. Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition
   Lianbi Zhao, Changyang Xing, Wenqi Sun, Guangli Hou, Guodong Yang, Lijun Yuan · 2018 · Cancer Chemotherapy and Pharmacology
6. Silver nanoparticles regulate autophagy through lysosome injury and cell hypoxia in prostate cancer cells
   Yue Chen, Tong Yang, Shiqun Chen, Shiyong Qi, Zhihong Zhang, Yong Xu · 2020 · Journal of Biochemical and Molecular Toxicology
7. Alterations, Interactions, and Diagnostic Potential of Gut Bacteria and Viruses in Colorectal Cancer
   Renyuan Gao, Yefei Zhu, Cheng Kong, Kai Xia, Hao Li, Yin Zhu, Xiaohui Zhang, Yongqiang Liu, Hui Zhong, Rong Yang et al. · 2021 · Frontiers in Cellular and Infection Microbiology
8. Emerging Evidence on the Effects of Dietary Factors on the Gut Microbiome in Colorectal Cancer
   Sandeep Appunni, Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Raees Tonse, Peter McGranaghan, Adeel Kaiser, Rupesh R Kotecha · 2021 · Frontiers in Nutrition
9. Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
   Naser, Rayan, Fakhoury, Isabelle, El‑Fouani, Adam, Abi‑Habib, Ralph, El‑Sibai, Mirvat · 2022 · International Journal of Oncology
10. The Impact of Gut Microbiota-Derived Metabolites on the Tumor Immune Microenvironment
    Maik Luu, Burkhard Schütz, Matthias Lauth, Alexander Visekruna · 2023 · Cancers
11. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance
    Linfu Chen, Rui Zhao, Zheyu Kang, Zhiqin Cao, Nanhui Liu, Jingjing Shen, Cheng Wang, Feng Pan, Xiao Zhou, Zhuang Liu et al. · 2023 · Journal of Controlled Release
12. Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
    Hyeon Jeong Oh, Jung Ho Kim, Jeong Mo Bae, Hyun Jung Kim, Nam‐Yun Cho, Gyeong Hoon Kang · 2018 · Journal of Pathology and Translational Medicine
13. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma
    Jiayun Jiang, Shihan Chen, Kun Li, Chang Zhang, Yunhua Tan, Qingsong Deng, Yuelong Chai, Xiaofei Wang, Geng Chen, Kai Feng et al. · 2019 · International Journal of Hyperthermia
14. Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status
    Lee, Ji Ae, Yoo, Seung-Yeon, Oh, Hyeon Jeong, Jeong, Seorin, Cho, Nam-Yun, Kang, Gyeong Hoon, Kim, Jung Ho · 2021 · Cancer Immunology, Immunotherapy
15. Microbiota transplantation: Targeting cancer treatment
    Xia Wu, Ting Zhang, Xiong Chen, Guozhong Ji, Faming Zhang · 2019 · Cancer Letters
16. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
    Dibyendu Dutta, Seah H. Lim · 2020 · Biomarker Research
17. Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer
    Shumpei Yamamoto, Hideaki Kinugasa, Mami Hirai, Hiroyuki Terasawa, Eriko Yasutomi, Shohei Oka, Masayasu Ohmori, Yasushi Yamasaki, Toshihiro Inokuchi, Keita Harada et al. · 2020 · Journal of Gastroenterology and Hepatology
18. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis
    Jing Zhou, Liu Jialing, Yangyang Gao, Liwei Shen, Sheng Li, Simin Chen · 2021 · Frontiers in Pharmacology
19. The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
    Feng Gao, Bo Yu, Benchen Rao, Ying Hao Sun, Jia Yu, Daming Wang, Guangying Cui, Zhigang Ren · 2022 · Frontiers in Immunology
20. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients
    Andrew T. Kunzmann, Marcela Alcântara Proença, Haydée W.T. Jordão, Kateřina Jirásková, Michaela Schneiderová, Miroslav Levý, Václav Liška, Tomáš Büchler, Ľudmila Vodičková, Veronika Polakova Vymetalkova et al. · 2019 · European Journal of Clinical Microbiology & Infectious Diseases
21. Roles of microbiota in response to cancer immunotherapy
    Kentaro Inamura · 2020 · Seminars in Cancer Biology
22. The tumor organismal environment: Role in tumor development and cancer immunotherapy
    Lothar C. Dieterich, Andréas Bikfalvi · 2019 · Seminars in Cancer Biology
23. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
    Bowen Li, Shibo Wei, Liang Yang, Xueqiang Peng, Yingbo Ma, Bo Wu, Qing Fan, Shuo Yang, Xinyu Li, Hongyuan Jin et al. · 2021 · Frontiers in Oncology
24. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
    Valentino Le Noci, Giancarla Bernardo, Francesca Bianchi, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini · 2021 · Frontiers in Cell and Developmental Biology
25. New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
    Jing Xu, Haoming Xu, Meifeng Yang, Yu-jie Liang, Quanzhou Peng, Yuan Zhang, Cheng‐mei Tian, Lisheng Wang, Jun Yao, Yuqiang Nie et al. · 2022 · Frontiers in Pharmacology
26. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models
    Jessica Queen, Jada C. Domingue, James Robert White, Courtney M. Stevens, Barath Udayasuryan, Tam T. D. Nguyen, Shaoguang Wu, Hua Ding, Hongni Fan, Madison McMann et al. · 2022 · mBio
27. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis
    Ruohan Li, Xiao Li, Tao Gong, Jiaxin Liu, Yuqing Li, Xuedong Zhou, Yi Li, Xin Min Zheng · 2022 · Molecular Oral Microbiology
28. Gut microbiome–driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming
    Jhommara Bautista, Mónica Lamas Maceiras, Camila Hidalgo‐Tinoco, Antonio Guerra-Guerrero, Anapaula Betancourt-Velarde, Andrés López‐Cortés · 2026 · npj Biofilms and Microbiomes
29. Global Investigations of Fusobacterium nucleatum in Human Colorectal Cancer
    Seul A. Lee, Fang Liu, Stephen M. Riordan, Cheok S. Lee, Li Zhang · 2019 · Frontiers in Oncology
30. CircRNA_100565 contributes to cisplatin resistance of NSCLC cells by regulating proliferation, apoptosis and autophagy via miR-337-3p/ADAM28 axis
    Youqing Zhong, Hui Lin, Qi Li, Chang Liu, Jinmei Shen · 2021 · Cancer Biomarkers
31. The role of the bacterial microbiome in the treatment of cancer
    Zi‐Kun Yu, Ruiling Xie, Rui You, You‐Ping Liu, Xu-Yin Chen, Ming‐Yuan Chen, Pei-Yu Huang · 2021 · BMC Cancer
32. Crosstalk between autophagy and microbiota in cancer progression
    Yu Wang, Jiang Du, Xuemei Wu, Ahmed Abdelrehem, Yu Ren, Chao Liu, Xuan Zhou, Sinan Wang · 2021 · Molecular Cancer
33. The microbiome of pancreatic cancer: from molecular diagnostics to new therapeutic approaches to overcome chemoresistance caused by metabolic inactivation of gemcitabine
    Arthur T.F. Choy, Ilaria Carnevale, Stefano Coppola, Laura L. Meijer, Geert Kazemier M, Egija Zaura, Dongmei Deng, Elisa Giovannetti · 2018 · Expert Review of Molecular Diagnostics
34. The Role of the Microbiome in Drug Response
    Rosina E. Pryor, Daniel Martínez‐Martínez, Leonor M. Quintaneiro, Filipe Cabreiro · 2019 · The Annual Review of Pharmacology and Toxicology
35. Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities
    A. Allegra, C. Musolino, A. Tonacci, G. Pioggia, S. Gangemi · 2020 · Cancers
36. Intestinal Microbiota in Colorectal Cancer Surgery
    Ioannis Koliarakis, Elias Athanasakis, Markos N. Sgantzos, Theodoros D. Mariolis-Sapsakos, Evangelos Xynos, Emmanuel Chrysos, John Souglakos, John Tsiaoussis · 2020 · Cancers
37. Novel scheme for non-invasive gut bioinformation acquisition with a magnetically controlled sampling capsule endoscope
    Zhen Ding, Weijun Wang, Kun Zhang, Fanhua Ming, Tianyi Yangdai, Tao Xu, Huiying Shi, Yuhui Bao, Hailing Yao, Hangyu Peng et al. · 2021 · Gut
38. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance
    Rana Shafabakhsh, Farzaneh Arianfar, Massoud Vosough, Hamid Reza Mirzaei, Maryam Mahjoubin‐Tehran, Hashem Khanbabaei, Hamed Kowsari, Layla Shojaie, Maryam Ebadi Fard Azar, Michael Richard Hamblin et al. · 2021 · Cancer Gene Therapy
39. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated Fusobacterium nucleatum ssp. animalis
    Dimitra Lamprinaki, Pilar García-Vello, Roberta Marchetti, Charlotte Hellmich, Kelli A. McCord, Kristian M. Bowles, Matthew Scott Macauley, Alba Silipo, Cristina De Castro, Paul R. Crocker et al. · 2021 · Frontiers in Immunology
40. Roles of microbiota in pancreatic cancer development and treatment
    Mariana Santos Cruz, Joseph Tintelnot, Nicola Gagliani · 2024 · Gut Microbes
41. Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics
    Fei Peng, Mengyuan Hu, Zhiyue Su, Lin Hu, Lingchuan Guo, Kai Yang · 2024 · Advanced Materials
42. Emerging Approaches of Cell‐Based Nanosystems to Target Cancer Metastasis
    Xiang Gong, Jie Li, Tao Tan, Zhiwan Wang, Hong Wang, Yuqi Wang, Xiaoxuan Xu, Zhiwen Zhang, Yaping Li · 2019 · Advanced Functional Materials
43. miRNA–Microbiota Interaction in Gut Homeostasis and Colorectal Cancer
    Jiayi Dong, Jesse W. Tai, Li‐Fan Lu · 2019 · Trends in cancer
44. Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with <i>Fusobacterium nucleatum</i> and Its Subspecies <i>animalis</i>
    Borozan, Ivan, Zaidi, Syed H., Harrison, Tabitha A., Phipps, Amanda I., Zheng, Jiayin, Lee, Stephen, Trinh, Quang M., Steinfelder, Robert S., Adams, Jeremy, Banbury, Barbara L. et al. · 2022 · Cancer Epidemiology, Biomarkers &amp; Prevention
45. lncRNA ZNF649-AS1 Induces Trastuzumab Resistance by Promoting ATG5 Expression and Autophagy
    Mingli Han, Xueke Qian, Hui Cao, Fang Wang, Xiangke Li, Na Han, Xue Yang, Yunqing Yang, Dongwei Dou, Jianguo Hu et al. · 2020 · Molecular Therapy
46. The relationship between gastrointestinal cancers and the microbiota
    Kaitlyn D. LaCourse, Christopher D. Johnston, Susan Bullman · 2021 · The Lancet. Gastroenterology & hepatology
47. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
    Mjriam Capula, Macarena Perán, Geng Xu, Valentina Laura Donati, Dicky Yee, Alessandro Gregori, Yehuda G. Assaraf, Elisa Giovannetti, Dongmei Deng · 2022 · Drug Resistance Updates
48. Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
    Jia-Hao Dai, Xi-Rong Tan, Han Qiao, Na Liu · 2023 · Protein & Cell
49. Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria
    Linfu Chen, Jingjing Shen, Zheyu Kang, Zemin Zhang, Zixuan Zheng, Lin Zhang, Zhisheng Xiao, Qiang Zhang, Huapan Fang, Jun Zhou et al. · 2024 · Chem
50. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner
    Barath Udayasuryan, Zirui Zhou, Raffae N. Ahmad, Polina Sobol, Chengyu Deng, Tam T. D. Nguyen, Shivanie Kodikalla, Ryan G. Morrison, Ishan Goswami, Daniel Joseph Slade et al. · 2024 · Communications Biology
51. Food, microbiome and colorectal cancer
    Lukas Niederreiter, Timon Erik Adolph, Herbert Tilg · 2018 · Digestive and Liver Disease
52. Role of the intestinal microbiome in colorectal cancer surgery outcomes
    Lelde Lauka, Elisa Reitano, Maria Clotilde Carra, Federica Gaiani, Paschalis Gavriilidis, Francesco Brunetti, Gian Luigi de’Angelis, Iradj Sobhani, Nicola de’Angelis · 2019 · World Journal of Surgical Oncology
53. Gut Microbiota Dynamics during Chemotherapy in Epithelial Ovarian Cancer Patients Are Related to Therapeutic Outcome
    Federica D’Amico, Anna Myriam Perrone, Simone Rampelli, Sara Coluccelli, Monica Barone, Gloria Ravegnini, Marco Fabbrini, Patrizia Brigidi, Pierandrea De Iaco, Silvia Turroni · 2021 · Cancers
54. Microbiota and Colorectal Cancer: From Gut to Bedside
    Miguel G. Silva, Valentina Brunner, Markus Tschurtschenthaler · 2021 · Frontiers in Pharmacology
55. Alterations in the oral and gut microbiome of colorectal cancer patients and association with host clinical factors
    Yao Wang, Yao Zhang, Yun Qian, Yuanhong Xie, Shanshan Jiang, Zi‐Ran Kang, Yingxuan Chen, Zhao‐Fei Chen, Jing‐Yuan Fang · 2021 · International Journal of Cancer
56. Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers
    Han Sang Kim, Chang Gon Kim, Won Kyu Kim, Kyung‐A Kim, Jinseon Yoo, Byung Soh Min, Soonmyung Paik, Sang Joon Shin, Hyukmin Lee, Kyungwon Lee et al. · 2023 · Frontiers in Cellular and Infection Microbiology
57. Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
    Yao Liu, Lili Niu, Nannan Li, Yang Wang, Mingyang Liu, Xiaomin Su, Xuhui Bao, Bo Yin, Shun Shen · 2023 · Advanced Science
58. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer
    Alyssa A. Leystra, Margie L. Clapper · 2019 · Genes
59. The DNA Glycosylase NEIL2 Suppresses Fusobacterium-Infection-Induced Inflammation and DNA Damage in Colonic Epithelial Cells
    Ibrahim M. Sayed, Anirban Chakraborty, Amer Ali Abd El‐Hafeez, Aditi Sharma, Ayse Z. Sahan, Wendy Jia Men Huang, Debashis Sahoo, Pradipta Ghosh, Tapas K. Hazra, Soumita Das · 2020 · Cells
60. Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer
    Yan Chen, Yingxuan Chen · 2021 · Cancers
61. Gut microbiota modulation: a tool for the management of colorectal cancer
    Yan Wang, Hui Li · 2022 · Journal of Translational Medicine
62. Intratumoral microbiota: A new force in diagnosing and treating pancreatic cancer
    Zhengting Jiang, Wenjie Zhang, Zhilin Zhang, Gengyu Sha, Daorong Wang, Dong Tang · 2022 · Cancer Letters
63. The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer
    Dashuang Sheng, Kaile Yue, Hongfeng Li, Lanlan Zhao, Guoping Zhao, Chuandi Jin, Lei Zhang · 2023 · Microbiology Spectrum
64. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation
    Mary Garvey · 2024 · Biomedicines
65. Biofilm formation by the host microbiota: a protective shield against immunity and its implication in cancer
    Elena Montanari, Giancarla Bernardo, Valentino Le Noci, Martina Anselmi, Serenella Maria Pupa, Elda Tagliabue, Michele Sommariva, Lucia Sfondrini · 2025 · Molecular Cancer
66. Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy
    Jinfei Tong, Xiao Zhang, Yunlong Fan, Lingfeng Chen, Xudong Ma, Hailan Yu, Jianqiong Li, Xiaojing Guan, Peiya Zhao, Jianhua Yang · 2020 · Cancer Management and Research
67. Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity
    Chushu Li, Han Yao, Huanbin Wang, Jing‐Yuan Fang, Jie Xu · 2020 · Oncogene
68. RNA landscape of the emerging cancer-associated microbe Fusobacterium nucleatum
    Falk Ponath, Caroline Tawk, Yan Zhu, Lars Barquist, Franziska Faber, Jörg Vogel · 2021 · Nature Microbiology
69. Untitled work
    2022 · 10.1016/j.hsr.2021.100010
70. The onco-immunological implications of Fusobacterium nucleatum in breast cancer
    Michelle van der Merwe, Gustav van Niekerk, Alfred Botha, Anna‐Mart Engelbrecht · 2021 · Immunology Letters
71. Fusobacterium nucleatum and Colorectal Cancer
    Rongrong Li, Jilu Shen, Yuanhong Xu · 2022 · Infection and Drug Resistance
72. Fusobacterium nucleatum Extracellular Vesicles Promote Experimental Colitis by Modulating Autophagy via the miR-574-5p/CARD3 Axis
    Shuchun Wei, Jixiang Zhang, Xiaohan Wu, Meilin Chen, Hancheng Huang, Suqi Zeng, Zixuan Xiang, Xiangyun Li, Weiguo Dong · 2022 · Inflammatory Bowel Diseases
73. Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy
    Euna Choi, Ben Murray, Sunga Choi · 2023 · International Journal of Molecular Sciences
74. Worlds Apart – Transcriptome Profiles of Key Oral Microbes in the Periodontal Pocket Compared to Single Laboratory Culture Reflect Synergistic Interactions
    Zhi-Luo Deng, Helena Sztajer, Michael Jarek, Sabin Bhuju, Irene Wagner‐Döbler · 2018 · Frontiers in Microbiology
75. Butyrate upregulates the TLR4 expression and the phosphorylation of MAPKs and NK‑κB in colon cancer cell in�vitro
    Tengfei Xiao, Shuiyun Wu, Cheng Yan, Chuanxiang Zhao, Huimin Jin, Nannan Yan, Jie Xu, Yi Wu, Ci Li, Qixiang Shao et al. · 2018 · Oncology Letters
76. Brefeldin A inhibits colorectal cancer growth by triggering Bip/Akt‐regulated autophagy
    Li Zhou, Wei Qiang Gao, Kui Wang, Zhao Huang, Lu Zhang, Zhe Zhang, Jing Zhou, Edouard Collins Nice, Canhua Huang · 2019 · The FASEB Journal
77. Utilizing Whole Fusobacterium Genomes To Identify, Correct, and Characterize Potential Virulence Protein Families
    Ariana Umaña, Blake E. Sanders, Christopher C. Yoo, Michael A. Casasanta, Barath Udayasuryan, Scott S. Verbridge, Daniel Joseph Slade · 2019 · Journal of Bacteriology
78. Inhibiting autophagy enhances sulforaphane-induced apoptosis via targeting NRF2 in esophageal squamous cell carcinoma
    Zhaoming Lu, Yandan Ren, Li Yang, Ang Jia, Yi Hu, Yu Fen Zhao, Wuduo Zhao, Bin Yu, Wen He Zhao, Jianying Zhang et al. · 2020 · Acta Pharmaceutica Sinica B
79. LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer
    Rui Tang, Junhong Chen, Mengtian Tang, Zhiqiang Liao, Lianqing Zhou, Jiarui Jiang, Yingbin Hu, Qianjin Liao, Wei Xiong, Yanyan Tang et al. · 2019 · International Journal of Biological Sciences
80. C. tropicalis promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system
    Junxing Qu, Zhiheng Sun, Peng Chen, Daoqian Li, Wenyue Yan, Zhen Xu, Yayi Hou, Sunan Shen, Ping Chen, Tingting Wang · 2021 · International Journal of Biological Sciences
81. The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer
    Kaixi Liu, Xinran Yang, Mi Zeng, Yumeng Yuan, Jianhong Sun, Ping He, Jiayu Sun, Qingdong Xie, Xiaolan Chang, Suwei Zhang et al. · 2021 · Disease Markers
82. Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance
    Mengxia Liang, Yiwen Liu, Zheyuan Zhang, Haijun Yang, Ningtao Dai, Ning Zhang, Wei Yan Sun, Yibo Guo, Jinyu Kong, Xiaopeng Wang et al. · 2022 · Annals of Medicine
83. Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
    Gang Wang, Xianli He, Qian Wang · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
84. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs
    Xing Peng, Shuo Wang, Yu Qing Cao, Bo Liu, Feifei Zheng, Wei Guo, Jun-Hao Huang, Zimo Zhao, Ziyi Yang, Xingda Lin et al. · 2023 · Drug Resistance Updates
85. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
    Yalda Hekmatshoar, Yalda Rahbar Saadat, Seyed Mahdi Hosseiniyan Khatibi, Tülin Özkan, Fatemeh Zununi Vahed, Ziba Nariman‐Saleh‐Fam, Bahram Pourghassem Gargari, Asuman Sunguroğlu, Sepideh Zununi Vahed · 2019 · Life Sciences
86. Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development
    Gao, Zhifei, Jiang, Aimin, Li, Zizhuo, Zhu, Lingxuan, Mou, Weiming, Shen, Weitao, Luo, Peng, Tang, Bufu, Zhang, Jian, Lin, Anqi · 2025 · Med Research
87. Relationship between microsatellite status and immune microenvironment of colorectal cancer and its application to diagnosis and treatment
    Junge Bai, Hongsheng Chen, Xuefeng Bai · 2021 · Journal of Clinical Laboratory Analysis
88. Self‐Thermophoretic Nanoparticles Enhance Intestinal Mucus Penetration and Reduce Pathogenic Bacteria Interception in Colorectal Cancer
    Zhi‐Hao Wang, Wanting Huang, Shuhao Zhang, Mengyu Chu, Na Yin, Chaoran Zhu, Zhenzhong Zhang, Jinjin Shi, Junjie Liu · 2023 · Advanced Functional Materials
89. State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
    Tommaso Schepis, Sara Sofia De Lucia, Antonio Pellegrino, Angelo DEL GAUDIO, Rossella Maresca, Gaetano Coppola, Michele Francesco Chiappetta, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli et al. · 2023 · Cancers
90. cGAS-STING signaling pathway in intestinal homeostasis and diseases
    Yuchen Yang, Li Wang, Ivonne Peugnet-González, Daniela Parada‐Venegas, Gerard D. H. Dijkstra, Klaas Nico Faber · 2023 · Frontiers in Immunology
91. Chemoresistance and the tumor microenvironment: the critical role of cell–cell communication
    Bartosz Wilczyński, Alicja Dąbrowska, Julita Kulbacka, Dagmara Baczyńska · 2024 · Cell Communication and Signaling
92. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest
    Jorge Luis Galeano Niño, Falk Ponath, Victor A. Ajisafe, Clara R. Becker, Andrew G. Kempchinsky, Martha A. Zepeda‐Rivera, Javier A. Gomez, Hanrui Wu, Jessica G Terrazas, Heather K. Bouzek et al. · 2025 · Cancer Cell
93. Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance
    Priscilla Cascetta, Alessandro Cavaliere, Geny Piro, Lorena Torroni, Raffaela Santoro, Giampaolo Tortora, Davide Melisi, Carmine Carbone · 2018 · International Journal of Molecular Sciences
94. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
    Xiaowen Huang, Xialu Hong, Jilin Wang, Tiantian Sun, TaChung Yu, Yanan Yu, Jing‐Yuan Fang, Hua Xiong · 2020 · EBioMedicine
95. Viruses and Bacteria Associated with Cancer: An Overview
    Davide Zella, Robert C. Gallo · 2021 · Viruses
96. Colorectal cancer cells utilize autophagy to maintain mitochondrial metabolism for cell proliferation under nutrient stress
    Samantha N. Devenport, Rashi Singhal, Megan D. Radyk, Joseph Taranto, Samuel A. Kerk, Brandon Chen, Joshua W. Goyert, Chesta Jain, Nupur Kanti Das, Katherine I. Oravecz-Wilson et al. · 2021 · JCI Insight
97. Tumor microbiome metabolism: A game changer in cancer development and therapy
    Xiaozhuang Zhou, Shruthi Kandalai, Farzana Hossain, Qingfei Zheng · 2022 · Frontiers in Oncology
98. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities
    Man Wang, Fei Yu, Peifeng Li · 2023 · Frontiers in Immunology
99. Tumor microbiome: roles in tumor initiation, progression, and therapy
    Shengxin Zhang, Jing Huang, Zedong Jiang, Huan Tong, Xuelei Ma, Yang Liu · 2025 · Molecular Biomedicine
100. Integrated spatial multi‐omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression
     Feng Zhao, Rui An, Yilei Ma, Shaobo Yu, Yuzhen Gao, Yanzhong Wang, Haitao Yu, Xinyou Xie, Jun Zhang · 2025 · Clinical and Translational Medicine